市場調査レポート

商品コード

1390425

脱毛症治療市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Alopecia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: 2023年11月24日 | 発行: IMARC

| ページ情報: 英文 139 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 2,499 391,743円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,499 548,503円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,499 705,263円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

概要

脱毛症治療の世界市場規模は2022年に31億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに41億米ドルに達し、2022～2028年の成長率（CAGR）は4.77%になると予測しています。脱毛症の有病率の増加、脱毛の状態や治療法に関する意識の高まり、医療技術や治療法の進歩、政府による支援政策の実施などが、市場を推進している主な要因です。

脱毛症治療とは、著しい脱毛を特徴とする脱毛症の管理と対策に用いられる様々な手法を指します。脱毛症の種類には、男性型脱毛症、円形脱毛症、瘢痕性脱毛症などがあります。脱毛症の治療には、外用薬、内服薬、植毛手術、光線療法、多血小板血漿療法などがあります。脱毛症の治療は、脱毛の進行を遅らせ、発毛を促進し、健康な毛髪を維持し、外見を改善し、自信を高めるのに役立ちます。

男性型脱毛症や円形脱毛症を含む脱毛症の有病率の上昇は、効果的な治療法に対する需要を促進する主な要因の一つです。さらに、費用対効果の高い自毛植毛施術を提供する国々への医療ツーリズムが増加していることも、市場の成長に拍車をかけています。さらに、急速な都市化と可処分所得の増加が相まって、個人が高品質の治療計画を手に入れることができるようになったことも、市場成長に寄与しています。これとは別に、新製品や治療法に関する消費者の認知度を高めるために、製薬会社がソーシャルメディアやインフルエンサーマーケティングを通じて積極的なマーケティングやプロモーション戦略を展開していることも、市場成長に好影響を与えています。さらに、診察や処方へのアクセスを容易にする遠隔医療の出現が、市場の成長を強化しています。その他の要因としては、個別化医療に対する需要の高まり、広範な研究開発（R&D）活動、ファッションやエンターテインメント産業の影響力の高まりなどが挙げられ、市場成長の原動力になると予想されます。

脱毛症治療市場の動向と促進要因：

脱毛症の有病率の増加

脱毛症は様々な脱毛症状を包含し、世界中でますます流行しています。その誘因には、遺伝的素因、ホルモンバランスの乱れ、ストレス、および栄養不良、喫煙、化学物質への暴露、座りっぱなしのライフスタイルなどの生活習慣要因が含まれます。これらの誘因は、特に高齢化社会とストレスの多い環境で働く人々に増加しています。これに伴い、現代生活の急速なペースとプレッシャーにより、ストレス誘発性脱毛症が顕著に増加しています。これに伴い、遺伝的関連性の強い男性型脱毛症などの症状も、人口の増加や遺伝的形質の継承に伴い、より一般的になってきています。さらに、脱毛の原因となる多嚢胞性卵巣症候群（PCOS）や甲状腺疾患などの慢性疾患の増加も、脱毛症患者数の増加に寄与しています。

脱毛症と治療法に関する意識の高まり

オンラインで入手可能な情報が爆発的に増加し、啓発キャンペーンを通じて脱毛症に関する消費者の意識が高まっていることは、市場成長を促進する主な要因の1つです。様々な健康プラットフォーム、ソーシャルメディア、インフルエンサーコミュニティが、抜け毛、その意味合い、可能性のある治療法について活発に議論しており、この話題がタブーでなくなり、大衆の間でより理解されるようになっています。このような意識の高まりが意識の変化を引き起こし、専門家の助けや助言を求める傾向が高まっています。脱毛症の汚名返上と、脱毛症が治療可能な症状であることの理解は、治療に対する需要を大幅に増加させました。さらに、情報を得た消費者は、治療体制を長期間継続する可能性が高く、これも成長を促す要因となっています。

医療技術と治療法の進歩

毛髪と頭皮の研究である毛髪科学の分野では、近年著しい技術の進歩が見られます。脱毛症のタイプをより正確に特定し、より的を絞った治療を可能にする強化された診断ツールのイントロダクションが、市場の成長を後押ししています。さらに、低レベル光療法や多血小板血漿療法を含む新しい治療オプションの採用により、治療スペクトルが広がり、患者の転帰が改善されています。さらに、局所塗布用および経口摂取用の革新的な薬剤が最近開発され、脱毛症治療の有効性が向上したことも、市場の成長に寄与しています。こうした進歩により、消費者が利用できる治療法の選択肢が豊富になり、これらの治療法の有効性に対する信頼が高まっています。その結果、より多くの個人が脱毛症治療や療法に投資するようになり、市場成長を促進しています。

脱毛症治療産業のセグメンテーション

IMARC Groupは、世界の脱毛症治療市場レポートの各セグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国別レベルでの予測を提供しています。当レポートでは、薬剤タイプ、適応症、性別、投与経路、流通チャネルに基づいて市場を分類しています。

本レポートで扱う主な質問

2022年の脱毛症治療の世界市場規模は？
2023-2028年の脱毛症治療世界市場の予想成長率は？
脱毛症治療の世界市場を牽引する主要因は何か
COVID-19が世界の脱毛症治療市場に与えた影響は？
脱毛症治療の世界市場における薬剤タイプ別の区分は？
適応症に基づく脱毛症治療世界市場の内訳は？
脱毛症治療の世界市場の性別による区分は？
投与経路に基づく脱毛症治療世界市場の内訳は？
脱毛症治療世界市場の流通チャネル別区分は？
10.脱毛症治療の世界市場における主要地域は？
11.脱毛症治療の世界市場における主要プレイヤー/企業は？

北米
- 米国
  - 市場動向
  - 市場予測
- カナダ
  - 市場動向
  - 市場予測
アジア太平洋
- 中国
  - 市場動向
  - 市場予測
- 日本
  - 市場動向
  - 市場予測
- インド
  - 市場動向
  - 市場予測
- 韓国
  - 市場動向
  - 市場予測
- オーストラリア
  - 市場動向
  - 市場予測
- インドネシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
欧州
- ドイツ
  - 市場動向
  - 市場予測
- フランス
  - 市場動向
  - 市場予測
- 英国
  - 市場動向
  - 市場予測
- イタリア
  - 市場動向
  - 市場予測
- スペイン
  - 市場動向
  - 市場予測
- ロシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
ラテンアメリカ
- ブラジル
  - 市場動向
  - 市場予測
- メキシコ
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
中東・アフリカ地域
- 市場動向
- 市場内訳：国別
- 市場予測

第12章 SWOT分析

概要
強み
弱み
機会
脅威

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第15章価格分析

第16章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Aclaris Therapeutics Inc.
- Cellmid Limited
- Cipla Limited
- Dr. Reddy's Laboratories Ltd.
- GlaxoSmithKline plc
- HCell Inc.
- Johnson & Johnson
- Merck & Co. Inc.
- Pfizer Inc.
- Taisho Pharmaceutical Holdings Co. Ltd
- Teva Pharmaceutical Industries Ltd.

図表

List of Figures

Figure 1: Global: Alopecia Treatment Market: Major Drivers and Challenges
Figure 2: Global: Alopecia Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Alopecia Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Alopecia Treatment Market: Breakup by Drug Type (in %), 2022
Figure 5: Global: Alopecia Treatment Market: Breakup by Indication (in %), 2022
Figure 6: Global: Alopecia Treatment Market: Breakup by Gender (in %), 2022
Figure 7: Global: Alopecia Treatment Market: Breakup by Route of Administration (in %), 2022
Figure 8: Global: Alopecia Treatment Market: Breakup by Distribution Channel (in %), 2022
Figure 9: Global: Alopecia Treatment Market: Breakup by Region (in %), 2022
Figure 10: Global: Alopecia Treatment (Minoxidil) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Alopecia Treatment (Minoxidil) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Alopecia Treatment (Finasteride) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Alopecia Treatment (Finasteride) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Alopecia Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Alopecia Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Alopecia Treatment (Androgenic Alopecia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Alopecia Treatment (Androgenic Alopecia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Alopecia Treatment (Alopecia Areata) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Alopecia Treatment (Alopecia Areata) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Alopecia Treatment (Alopecia Totalis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Alopecia Treatment (Alopecia Totalis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Alopecia Treatment (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Alopecia Treatment (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Alopecia Treatment (Male) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Alopecia Treatment (Male) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Alopecia Treatment (Female) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Alopecia Treatment (Female) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Alopecia Treatment (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Alopecia Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Alopecia Treatment (Topical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Alopecia Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Alopecia Treatment (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Alopecia Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Alopecia Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Alopecia Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Alopecia Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Alopecia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Alopecia Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Alopecia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Alopecia Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Alopecia Treatment Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Alopecia Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Alopecia Treatment Industry: SWOT Analysis
Figure 90: Global: Alopecia Treatment Industry: Value Chain Analysis
Figure 91: Global: Alopecia Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Alopecia Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Alopecia Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 3: Global: Alopecia Treatment Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 4: Global: Alopecia Treatment Market Forecast: Breakup by Gender (in Million US$), 2023-2028
Table 5: Global: Alopecia Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 6: Global: Alopecia Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 7: Global: Alopecia Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Alopecia Treatment Market: Competitive Structure
Table 9: Global: Alopecia Treatment Market: Key Players

Product Code: SR112023A4147

Abstract

The global alopecia treatment market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 4.77% during 2022-2028. The increasing prevalence of alopecia, growing awareness about hair loss conditions and treatments, advancements in medical technologies and therapeutics, and the implementation of supportive government policies are some of the major factors propelling the market.

Alopecia treatment refers to various methodologies used to manage and combat Alopecia, a condition characterized by significant hair loss. The types of alopecia include androgenetic alopecia, alopecia areata, and cicatricial alopecia. Alopecia treatment consists of topical treatments, oral medications, hair transplant surgery, light therapy, and platelet-rich plasma therapy. It aids in slowing down hair loss progression, promoting hair regrowth, maintaining healthy hair, improving physical appearance, and enhancing self-confidence.

The rising prevalence of alopecia, including androgenetic alopecia and alopecia areata, is one of the key factors driving the demand for effective treatments. In addition, the rising medical tourism to countries offering cost-effective hair transplant procedures is fueling the market growth. Furthermore, rapid urbanization, coupled with the increasing disposable income, which allows individuals to afford high-quality treatment plans is contributing to the market growth. Apart from this, the aggressive marketing and promotional strategies by pharmaceutical companies through social media and influencer marketing to enhance consumer awareness about new products and treatments is favoring the market growth. Moreover, the emergence of telemedicine, which enables easier access to medical consultations and prescriptions is strengthening the market growth. Other factors, including the growing demand for personalized medicine, extensive research and development (R&D) activities, and the rising influence of fashion and entertainment industries, are anticipated to drive the market growth.

Alopecia Treatment Market Trends/Drivers:

The increasing prevalence of alopecia

Alopecia, encompassing a spectrum of hair loss conditions, is increasingly prevalent across the globe. Its triggers, include genetic predispositions, hormonal imbalances, stress, and lifestyle factors, such as poor nutrition, smoking, exposure to chemicals, and sedentary lifestyle. These triggers are rising especially in ageing populations and individuals working in highly stressful environments. In line with this, stress-induced Alopecia has witnessed a noticeable upswing due to the rapid pace and pressures of modern living. Along with this, conditions such as androgenetic alopecia, which has a strong genetic link, are becoming more common as populations grow and genetic traits are passed on. Moreover, the increasing prevalence of chronic diseases, such as polycystic ovary syndrome (PCOS) and thyroid disorders, which can lead to hair loss, is also contributing to the rising number of Alopecia cases.

The growing awareness about hair loss conditions and Treatments

The growing consumer awareness regarding hair loss conditions owing to an explosion of information available online and through concerted awareness campaigns is one of key factors propelling the market growth. Various health platforms, social media, and influencer communities are actively discussing hair loss, its implications, and possible remedies, making the topic less taboo and more understood among the masses. This heightened awareness has triggered a shift in attitudes, leading to a higher propensity to seek professional help and advice. The destigmatization of hair loss, coupled with the understanding that Alopecia is a treatable condition, has substantially increased the demand for treatments. Moreover, informed consumers are more likely to persist with the treatment regime for an extended period, which is acting as another growth-inducing factor.

Advancements in medical technologies and therapeutics

The field of trichology, the study of hair and scalp, has witnessed significant technological advancements in recent years. The introduction of enhanced diagnostic tools, which allows more precise identification of the Alopecia type and, therefore, more targeted treatments is boosting the market growth. Additionally, the adoption of novel treatment options, including low-level light therapy and platelet-rich plasma therapy, has broadened the treatment spectrum and improved patient outcomes. Furthermore, the recent development of innovative drugs for topical application and oral ingestion, which has improved the efficacy of Alopecia treatment is contributing to the market growth. These advancements have enriched the array of treatment options available to consumers and boosted their confidence in the effectiveness of these treatments. As a result, more individuals are investing in Alopecia treatment and therapies, thus propelling the market growth.

Alopecia Treatment Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global alopecia treatment market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on drug type, indication, gender, route of administration and distribution channel.

Breakup by Drug Type:

Minoxidil

Finasteride

Others

Minoxidil dominates the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes minoxidil, finasteride, and others. According to the report, minoxidil represented the largest market segment.

Minoxidil is dominating the market because its effectiveness and safety have been well-documented in numerous clinical studies, making it a trusted option for both physicians and patients. It is also one of the few treatments approved by various regulatory bodies across the globe for treating male and female pattern baldness. Furthermore, it is typically applied topically and can be incorporated into daily routines without much hassle. The non-invasive nature of the application, compared to surgical treatments, appeals to many patients. Moreover, Minoxidil is available in different forms, such as foams, lotions, and shampoos, offering a range of options to fit individual preferences. Apart from this, it can be obtained over the counter (OTC) without a prescription, which makes it more accessible to patients.

Breakup by Indication:

Androgenic Alopecia

Alopecia Areata

Alopecia Totalis

Others

Androgenic alopecia dominates the market

The report has provided a detailed breakup and analysis of the market based on the indication. This includes androgenic alopecia, alopecia areata, alopecia totalis, and others. According to the report, androgenic alopecia represented the largest market segment.

Androgenic alopecia is dominating the alopecia treatment market due to its high prevalence. It is the most common type of hair loss, affecting a significant percentage of the population, especially with increasing age. In addition, societal and personal perceptions of hair loss as a negative or undesirable condition drive demand for treatment. Hair is often associated with attractiveness, youth, and health, so hair loss can lead to lower self-esteem and confidence, prompting individuals to seek treatment. Moreover, androgenic alopecia has a strong genetic component and tends to be progressive if not treated, making it a target for long-term, sustained treatment approaches. This offers a steady demand for treatment products and therapies. Apart from this, the significant advancements in the treatment options for androgenic alopecia, including both pharmaceutical and surgical interventions, are acting as another growth-inducing factor.

Breakup by Gender:

Male

Female

Female dominates the market

The report has provided a detailed breakup and analysis of the market based on gender. This includes male and female. According to the report, female represented the largest market segment.

Female patients are dominating the market due to societal pressures and beauty standards, making them more likely to seek treatment. In addition, hair is often seen as a significant part of a woman's identity and appearance, and hair loss can have a profound psychological impact, leading to lower self-esteem and confidence. Furthermore, there are more treatment options available for female-pattern hair loss compared to male-pattern baldness. These include hormone therapy, topical treatments, and hair transplantation, giving women more opportunities to find a treatment that works for them. Additionally, hair loss in women can be caused by a wider range of factors than in men, including hormonal changes, stress, diet, certain medical conditions, and medications, leading to a larger proportion of women experiencing hair loss.

Breakup by Route of Administration:

Oral

Topical

Injectable

Topical dominates the market

The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral, topical, and injectable. According to the report, topical represented the largest market segment.

The topical route of administration is dominating the market as it is used as the first line of defense against hair loss. In addition, topical treatments are non-invasive and generally well-tolerated by patients. They can be easily applied to the affected area, allowing for targeted treatment. This localized application reduces the risk of systemic side effects, making it a safer option for many patients. Moreover, they are more affordable and accessible than other treatment options, such as hair transplants and laser treatments. Additionally, they are readily obtained over the counter (OTC) or through prescriptions, making them more convenient for patients. Apart from this, the use of topical treatments fits well into daily routines as patients can apply these medications at home, eliminating the need for regular visits to the doctor's office or clinic. This aspect of convenience greatly increases patient compliance, contributing to the efficacy of the treatment.

Breakup by Distribution Channel:

Hospitals

Retail Pharmacies

Online Pharmacies

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on distribution channel. This includes hospitals, retail pharmacies, and online pharmacies. According to the report, hospitals represented the largest market segment.

Hospitals are dominating the alopecia treatment market due to the wide range of treatment options they provide, including both surgical and non-surgical solutions for hair loss. In addition, they are equipped with the latest medical equipment and technologies, allowing them to provide advanced treatments such as hair transplantation surgeries, laser therapies, and steroid injections. Furthermore, hospitals employ experienced staff and specialized doctors, including dermatologists and trichologists, who are skilled in diagnosing and treating different types of alopecia. These professionals are able to guide patients toward effective treatment options based on their individual conditions. Additionally, they have in-house pharmacies, making it more convenient for patients to access prescribed medications, which improves adherence to treatment regimens, leading to better outcomes.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market, accounting for the largest alopecia treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represented the largest market segment.

North America is dominating the market due to a high prevalence of alopecia areata and androgenetic alopecia, which has increased the need for effective treatments. Additionally, the escalating awareness about the condition and available treatments owing to extensive educational campaigns by health authorities and companies is contributing to the market growth. Furthermore, the robust healthcare infrastructure and rising expenditure capacities in the region make it easier for patients to access high-quality treatment. In addition, the widespread availability of insurance coverage for these treatments plays a critical role in making them more affordable for a larger segment of the population. Apart from this, the presence of major pharmaceutical and biotech companies in the region that are actively engaged in the research and development of new treatments is boosting the market growth.

Competitive Landscape:

The key players in the market are actively investing in research and development (R&D) initiatives to discover innovative, effective treatments for alopecia. This includes the development of new drugs, novel application techniques, and treatments that tackle alopecia from different angles, such as targeting hormone levels, reducing inflammation, or stimulating hair follicles. Furthermore, leading companies are engaged in strategic partnerships and collaborations with biotech companies, research institutions, and universities to accelerate the pace of discovery and to pool resources and expertise. Additionally, the top companies are focusing on raising consumer awareness about the availability and effectiveness of various alopecia treatments through traditional and digital marketing channels. Moreover, key market players are conducting rigorous clinical trials to ensure their products meet stringent medical standards and regulatory requirements.

The report has provided a comprehensive analysis of the competitive landscape in the global alopecia treatment market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Aclaris Therapeutics Inc.

Cellmid Limited

Cipla Limited

Dr. Reddy's Laboratories Ltd.

GlaxoSmithKline plc

HCell Inc.

Johnson & Johnson

Merck & Co. Inc.

Pfizer Inc.

Taisho Pharmaceutical Holdings Co. Ltd

Teva Pharmaceutical Industries Ltd.

Recent Developments:

In Aug 2022, Aclaris Therapeutics Inc. announced a non-exclusive patent license agreement with Eli Lilly and Company to use Lilly's JAK inhibitor to treat alopecia areata (AA).

In September 2021, Dr. Reddy's Laboratories Ltd. launched a new drug to treat female pattern hair loss (FPHL)

In June 2023, FDA approved Pfizer's new oral treatment called Litfulo for treating alopecia in teens.

Key Questions Answered in This Report

1. What was the size of the global alopecia treatment market in 2022?
2. What is the expected growth rate of the global alopecia treatment market during 2023-2028?
3. What are the key factors driving the global alopecia treatment market?
4. What has been the impact of COVID-19 on the global alopecia treatment market?
5. What is the breakup of the global alopecia treatment market based on the drug type?
6. What is the breakup of the global alopecia treatment market based on the indication?
7. What is the breakup of the global alopecia treatment market based on gender?
8. What is the breakup of the global alopecia treatment market based on the route of administration?
9. What is the breakup of the global alopecia treatment market based on the distribution channel?
10. What are the key regions in the global alopecia treatment market?
11. Who are the key players/companies in the global alopecia treatment market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Alopecia Treatment Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Type

6.1 Minoxidil
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Finasteride
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Indication

7.1 Androgenic Alopecia
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Alopecia Areata
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Alopecia Totalis
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Gender

8.1 Male
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Female
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

9.1 Oral
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Topical
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Injectable
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Distribution Channel

10.1 Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Retail Pharmacies
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Online Pharmacies
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Aclaris Therapeutics Inc.
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
- 16.3.2 Cellmid Limited
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 Financials
- 16.3.3 Cipla Limited
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
  - 16.3.3.3 Financials
  - 16.3.3.4 SWOT Analysis
- 16.3.4 Dr. Reddy's Laboratories Ltd.
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 GlaxoSmithKline plc
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
  - 16.3.5.3 Financials
  - 16.3.5.4 SWOT Analysis
- 16.3.6 HCell Inc.
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 Johnson & Johnson
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 Financials
  - 16.3.7.4 SWOT Analysis
- 16.3.8 Merck & Co. Inc.
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Pfizer Inc.
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
  - 16.3.9.4 SWOT Analysis
- 16.3.10 Taisho Pharmaceutical Holdings Co. Ltd
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
- 16.3.11 Teva Pharmaceutical Industries Ltd.
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
  - 16.3.11.3 Financials
  - 16.3.11.4 SWOT Analysis

脱毛症治療市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Alopecia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

概要

脱毛症治療市場の動向と促進要因：

脱毛症治療産業のセグメンテーション

本レポートで扱う主な質問

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 脱毛症治療の世界市場

第6章 市場内訳：薬剤タイプ別

第7章 市場内訳：適応症別

第8章 市場内訳：男女別

第9章 市場内訳：投与経路別

第10章 市場内訳：流通チャネル別

第11章 市場内訳：地域別

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格分析

第16章 競合情勢

List of Figures

List of Tables

Abstract

Alopecia Treatment Market Trends/Drivers:

Alopecia Treatment Industry Segmentation:

Breakup by Drug Type:

Breakup by Indication:

Breakup by Gender:

Breakup by Route of Administration:

Breakup by Distribution Channel:

Breakup by Region:

Competitive Landscape:

The report has provided a comprehensive analysis of the competitive landscape in the global alopecia treatment market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Recent Developments:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Alopecia Treatment Market

6 Market Breakup by Drug Type

7 Market Breakup by Indication

8 Market Breakup by Gender

9 Market Breakup by Route of Administration

10 Market Breakup by Distribution Channel

11 Market Breakup by Region

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Analysis

16 Competitive Landscape

第1章序文

第2章調査範囲と調査手法

第3章エグゼクティブサマリー

第4章イントロダクション

第5章脱毛症治療の世界市場

第6章市場内訳：薬剤タイプ別

第7章市場内訳：適応症別

第8章市場内訳：男女別

第9章市場内訳：投与経路別

第10章市場内訳：流通チャネル別

第11章市場内訳：地域別

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

第15章価格分析

第16章競合情勢